MLTX

MoonLake Immunotherapeutics

Jun 23 • 04:00PM ET

21.22

-0.94 -4.24 %

Healthcare • Biotechnology • Switzerland • Small • NASD

Peers: ARQT MANE ORKA KRYS KYMR NUVL AXSM BMRN RYTM INCY

| Held by: VHT DWAS ESML PTH NUSC ONEQ OPTZ FHLC BBC TMED

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.87	Insider Own	14.01%	Shs Outstand	72.13M	Perf Week	10.58%
Market Cap	1.56B	Forward P/E	-	EPS next Y	-3.64	Insider Trans	-28.99%	Shs Float	63.30M	Perf Month	14.89%
Enterprise Value	1.30B	PEG	-	EPS next Q	-0.93	Inst Own	82.08%	Short Float	8.80%	Perf Quarter	25.79%
Income	-257.08M	P/S	-	EPS this Y	-8.61%	Inst Trans	15.47%	Short Ratio	5.28	Perf Half Y	60.03%
Sales	0.00M	P/B	6.03	EPS next Y	4.99%	ROA	-56.40%	Short Interest	5.57M	Perf YTD	61.00%
Book/sh	3.52	P/C	4.36	EPS next 5Y	6.32%	ROE	-77.72%	52W High	62.75 -66.18%	Perf Year	-52.71%
Cash/sh	4.86	P/FCF	-	EPS past 3/5Y	-27.48% -256.78%	ROIC	-72.64%	52W Low	5.95 256.64%	Perf 3Y	-18.01%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.75% 5.60%	Perf 5Y	104.43%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-68.11%	Oper. Margin	-	ATR (14)	1.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	65.24	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	8.60	EPS Q/Q	-54.82%	SMA20	12.94%	Beta	1.01	Target Price	30.64
Payout	-	Debt/Eq	0.40	Sales Q/Q	-	SMA50	17.79%	Rel Volume	1.67	Prev Close	22.16
Employees	130	LT Debt/Eq	0.39	Earnings	May 10 AMC	SMA200	15.08%	Avg Volume	1.05M	Price	21.22
IPO	Oct 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.89% -	Trades		Volume	1,737,430	Change	-4.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)